Potassium, sodium and tris oxaprozin salt pharmaceutical formula

Details Potassium, sodium and tris oxaprozin salt pharmaceutical formula Potassium, sodium and tris oxaprozin salt pharmaceutical formula

1997-05-16

2000-02-29

Spear, James M.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424465, 514777, 514778, 514781, 514784, 514886, A61K 920

Patent

active

060306432

ABSTRACT:
Pharmaceutical compositions containing potassium, sodium or Tris salt of oxaprozin as an active agent. The pharmaceutical compositions of the present invention are useful in eliminating or ameliorating pain and in the treatment of inflammation and inflammation associated disorders such as rheumatoid arthritis and osteoarthritis.

REFERENCES:
patent: 3578671 (1971-05-01), Woodley
patent: 3998815 (1976-12-01), Bodor
patent: 4160099 (1979-07-01), Bodor
patent: 4190584 (1980-02-01), Weston
patent: 4385049 (1983-05-01), Cuca
patent: 4465838 (1984-08-01), Mughal
patent: 4532253 (1985-07-01), Mughal
patent: 4599359 (1986-07-01), Cooper
patent: 5059626 (1991-10-01), Park
patent: 5350769 (1994-09-01), Kasai
Copy of article entitled: "Searle's New Commitment to Market-Driven Science" from Searle Internal Magazine ("Circlet")--vol. 47, No. 23, Nov. 21, 1994.

Affiliated with

Also associated with

Rating

Potassium, sodium and tris oxaprozin salt pharmaceutical formula does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Potassium, sodium and tris oxaprozin salt pharmaceutical formula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium, sodium and tris oxaprozin salt pharmaceutical formula will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-680395